196 related articles for article (PubMed ID: 24179016)
1. Adipokines promote chronic kidney disease.
Rüster C; Wolf G
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv8-14. PubMed ID: 24179016
[TBL] [Abstract][Full Text] [Related]
2. Adipokines as a link between obesity and chronic kidney disease.
Briffa JF; McAinch AJ; Poronnik P; Hryciw DH
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1629-36. PubMed ID: 24107418
[TBL] [Abstract][Full Text] [Related]
3. Obesity and Kidney Disease.
Lakkis JI; Weir MR
Prog Cardiovasc Dis; 2018; 61(2):157-167. PubMed ID: 29981350
[TBL] [Abstract][Full Text] [Related]
4. The adipose tissue as an endocrine organ.
Adamczak M; Wiecek A
Semin Nephrol; 2013 Jan; 33(1):2-13. PubMed ID: 23374889
[TBL] [Abstract][Full Text] [Related]
5. Obesity and adipokines: effects on sympathetic overactivity.
Smith MM; Minson CT
J Physiol; 2012 Apr; 590(8):1787-801. PubMed ID: 22351630
[TBL] [Abstract][Full Text] [Related]
6. Adipokines and the cardiovascular system: mechanisms mediating health and disease.
Northcott JM; Yeganeh A; Taylor CG; Zahradka P; Wigle JT
Can J Physiol Pharmacol; 2012 Aug; 90(8):1029-59. PubMed ID: 22646022
[TBL] [Abstract][Full Text] [Related]
7. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
Chalmers L; Kaskel FJ; Bamgbola O
Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
[TBL] [Abstract][Full Text] [Related]
8. Adipokines protecting CKD.
Miyamoto S; Sharma K
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4(Suppl 4):iv15-22. PubMed ID: 24179009
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase-1 and adipokines: Potential links between obesity and atherosclerosis.
Fülöp P; Harangi M; Seres I; Paragh G
Chem Biol Interact; 2016 Nov; 259(Pt B):388-393. PubMed ID: 27062889
[TBL] [Abstract][Full Text] [Related]
10. Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome.
Carmina E
Front Horm Res; 2013; 40():40-50. PubMed ID: 24002404
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin and cardiovascular disease: state of the art?
Szmitko PE; Teoh H; Stewart DJ; Verma S
Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1655-63. PubMed ID: 17142348
[TBL] [Abstract][Full Text] [Related]
12. Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction.
Lynch M; Ahern T; Sweeney CM; Malara A; Tobin AM; O'Shea D; Kirby B
Int J Dermatol; 2017 Nov; 56(11):1103-1118. PubMed ID: 28762474
[TBL] [Abstract][Full Text] [Related]
13. The metabolic syndrome and chronic kidney disease.
Zhang X; Lerman LO
Transl Res; 2017 May; 183():14-25. PubMed ID: 28025032
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of endothelial dysfunction in chronic kidney disease.
Malyszko J
Clin Chim Acta; 2010 Oct; 411(19-20):1412-20. PubMed ID: 20598675
[TBL] [Abstract][Full Text] [Related]
15. [Research Progress of Adipokine and Kidney Disease].
Zhang RX; Zhang X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Feb; 43(1):130-135. PubMed ID: 33663674
[TBL] [Abstract][Full Text] [Related]
16. Childhood Obesity and the Metabolic Syndrome.
Nehus E; Mitsnefes M
Pediatr Clin North Am; 2019 Feb; 66(1):31-43. PubMed ID: 30454749
[TBL] [Abstract][Full Text] [Related]
17. Adipokines and psoriasis.
Gerdes S; Rostami-Yazdi M; Mrowietz U
Exp Dermatol; 2011 Feb; 20(2):81-7. PubMed ID: 21255085
[TBL] [Abstract][Full Text] [Related]
18. Pro-Inflammatory Profile of Adipokines in Obesity Contributes to Pathogenesis, Nutritional Disorders, and Cardiovascular Risk in Chronic Kidney Disease.
Czaja-Stolc S; Potrykus M; Stankiewicz M; Kaska Ł; Małgorzewicz S
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35406070
[TBL] [Abstract][Full Text] [Related]
19. Adipokines as uremic toxins.
Teta D
J Ren Nutr; 2012 Jan; 22(1):81-5. PubMed ID: 22200420
[TBL] [Abstract][Full Text] [Related]
20. Obesity, inflammation, and kidney disease.
Navarro-Díaz M; Serra A; López D; Granada M; Bayés B; Romero R
Kidney Int Suppl; 2008 Dec; (111):S15-8. PubMed ID: 19034319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
